6,462
Views
11
CrossRef citations to date
0
Altmetric
Review

Intravenous fosfomycin for the treatment of patients with central nervous system infections: evaluation of the published evidence

, , &
Pages 657-668 | Received 04 Feb 2020, Accepted 07 Apr 2020, Published online: 13 May 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Marios Karvouniaris, Alexandros Brotis, Konstantinos Tsiakos, Eleni Palli & Despoina Koulenti. (2022) Current Perspectives on the Diagnosis and Management of Healthcare-Associated Ventriculitis and Meningitis. Infection and Drug Resistance 15, pages 697-721.
Read now
Sara Baldelli, Matteo Cerea, Davide Mangioni, Laura Alagna, Antonio Muscatello, Alessandra Bandera & Dario Cattaneo. (2022) Fosfomycin therapeutic drug monitoring in real-life: development and validation of a LC-MS/MS method on plasma samples. Journal of Chemotherapy 34:1, pages 25-34.
Read now

Articles from other publishers (9)

Denisa Pérez Gaudio, Sandra Pérez, Joaquín Mozo, Guadalupe Martínez, Julieta Decundo, Susana Dieguez & Alejandro Soraci. (2023) Fosfomycin modifies the replication kinetics of bovine alphaherpesvirus-1 and reduces the timing of its protein expression on bovine (MDBK) and human (SH-SY5Y) cell lines. Veterinary Research Communications 47:4, pages 1963-1972.
Crossref
Tzu-Ting Chen, Yun-Fu Chang & Yea-Chwen Wu. (2023) Clinical Use of Intravenous Fosfomycin in Critical Care Patients in Taiwan. Pathogens 12:6, pages 841.
Crossref
George Zhanel, Melanie Baxter, Maggie Wong, Yazdan Mirzanejad, Anna Lee, Rita Dhami, Justin Kosar, Denise Werry, Neal Irfan, Jean-Francois Tessier, Gabriel Girourd, Carlo Tascini, Teagen Rolf von den Baumen, Andrew Walkty & James A. Karlowsky. (2023) Real-life experience with IV fosfomycin in Canada: Results from the Canadian LEadership on Antimicrobial Real-life usage (CLEAR) registry. Journal of Global Antimicrobial Resistance 33, pages 171-176.
Crossref
Beata Kowalska-Krochmal, Beata Mączyńska, Danuta Rurańska-Smutnicka, Anna Secewicz, Grzegorz Krochmal, Małgorzata Bartelak, Aleksandra Górzyńska, Klaudyna Laufer, Krystyna Woronowicz, Joanna Łubniewska, Jolanta Łappo, Magdalena Czwartos & Ruth Dudek-Wicher. (2022) Assessment of the Susceptibility of Clinical Gram-Negative and Gram-Positive Bacterial Strains to Fosfomycin and Significance of This Antibiotic in Infection Treatment. Pathogens 11:12, pages 1441.
Crossref
Batoul Darwish, Farah Chamaa, Bassel Awada, Nada Lawand, Nayef E. Saadé, Antoine G. Abou Fayad & Wassim Abou-Kheir. (2022) Urinary Tract Infections Impair Adult Hippocampal Neurogenesis. Biology 11:6, pages 891.
Crossref
Abhijit M. Bal & Malini R. Capoor. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 100 105 .
Roland Nau, Fritz Sörgel & Helmut Eiffert. (2021) Central nervous system infections and antimicrobial resistance: an evolving challenge. Current Opinion in Neurology 34:3, pages 456-467.
Crossref
Francesco Ciummo, Pavithra Srinivas & Jessica Biedny. (2021) Antimicrobial use in central nervous system infections. Current Opinion in Infectious Diseases 34:3, pages 255-263.
Crossref
Weerayuth Saelim, Dhitiwat Changpradub, Sudaluck Thunyaharn, Piraporn Juntanawiwat, Parnrada Nulsopapon & Wichai Santimaleeworagun. (2021) Colistin plus Sulbactam or Fosfomycin against Carbapenem-Resistant Acinetobacter baumannii : Improved Efficacy or Decreased Risk of Nephrotoxicity? . Infection & Chemotherapy 53:1, pages 128.
Crossref